These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2752133)

  • 1. Prognosis of aggressive lymphomas: a study of five prognostic models with patients included in the LNH-84 regimen.
    Coiffier B; Lepage E
    Blood; 1989 Aug; 74(2):558-64. PubMed ID: 2752133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
    J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
    Morel P; Dupriez B; Herbrecht R; Bastion Y; Tilly H; Delannoy A; Haioun C; Nouvel C; Bouabdallah K; Baumelou E
    Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.
    Salles G; Herbrecht R; Tilly H; Berger F; Brousse N; Gisselbrecht C; Coiffier B
    Am J Med; 1991 Jan; 90(1):77-84. PubMed ID: 1702581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
    Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.
    Magrath IT; Janus C; Edwards BK; Spiegel R; Jaffe ES; Berard CW; Miliauskas J; Morris K; Barnwell R
    Blood; 1984 May; 63(5):1102-11. PubMed ID: 6546890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study.
    Fermé C; Bastion Y; Brice P; Lederlin P; Diviné M; Gabarre J; Assouline D; Ferrant A; Berger F; Lepage E
    Cancer; 1997 Sep; 80(6):1124-33. PubMed ID: 9305714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive chemotherapy in aggressive lymphomas: updated results of LNH-80 protocol and prognostic factors affecting response and survival.
    Coiffier B; Bryon PA; Ffrench M; Blanc M; Sebban C; Berger F; Viala JJ
    Blood; 1987 Nov; 70(5):1394-9. PubMed ID: 2444287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
    Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of aggressive primary lymphomas of the digestive system by intensive chemotherapy. Experience of the Study Group on Lymphomas in Adults with the LNH-84 protocol].
    Salles G; Herbrecht R; Brice P; Sebbań C; Tilly H; Lederlin P; Berger F; Coiffier B
    Ann Gastroenterol Hepatol (Paris); 1992; 28(4):205-8. PubMed ID: 1280028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
    Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
    Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
    Coiffier B; Gisselbrecht C; Herbrecht R; Tilly H; Bosly A; Brousse N
    J Clin Oncol; 1989 Aug; 7(8):1018-26. PubMed ID: 2474057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNM staging system may be superior to Lugano and Ann Arbor systems in predicting the overall survival of patients with primary gastrointestinal lymphoma.
    Chang S; Shi X; Xu Z; Liu Q
    J BUON; 2015; 20(3):812-9. PubMed ID: 26214635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
    Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
    Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.
    Decaudin D; Lepage E; Brousse N; Brice P; Harousseau JL; Belhadj K; Tilly H; Michaux L; Chèze S; Coiffier B; Solal-Céligny P
    J Clin Oncol; 1999 Aug; 17(8):2499-505. PubMed ID: 10561315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years.
    Bastion Y; Berger F; Bryon PA; Felman P; Ffrench M; Coiffier B
    Ann Oncol; 1991 Feb; 2 Suppl 2():123-9. PubMed ID: 2049309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary peripheral nodal lymphoma in children.
    Wollner N; Exelby P; Lindsley KL; Lieberman P; Filippa D; Heller G
    Cancer; 1993 Jun; 71(11):3670-9. PubMed ID: 8490916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).
    Coiffier B; Brousse N; Peuchmaur M; Berger F; Gisselbrecht C; Bryon PA; Diebold J
    Ann Oncol; 1990; 1(1):45-50. PubMed ID: 1706610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.